Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...

Hyderabad: Amid rising fears of US President Donald Trump imposing tariffs on Indian pharma imports, Aurobindo Pharma is ...

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

Image source: Getty Images. What: Shares of Lannett Company, Inc. (NYSE: LCI), a midsized generic drugmaker, packed on 25.2% last month, according to data from S&P Global Market Intelligence.

Founded in 1942, Lannett Company is a Philadelphia-based developer, manufacturer, marketer, and distributor of generic pharmaceuticals for a broad spectrum of indications. The company has seen its ...

In response to reporting fiscal second-quarter results, shares of Lannett Company, Inc. (NYSE: LCI), a producer of generic drugs, fell 11% as of 3:53 p.m. EST on Thursday. Here's a look at the ...

An evaluation of Lannett’s recent purchase of Kremers Urban provides insight into an appealing boost to the company’s product diversification and pipeline. A discussion of Lannett’s fall in ...

About Lannett Company, Inc.: Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.

PHILADELPHIA, Aug. 25, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 fourth quarter and full year ended June 30, 2021. "With the ...

Welcome to the Lannett Company Fiscal 2021 Fourth Quarter and Full Year Financial Results Conference Call. My name is Adrianne, and I will be your operator for today's call.